Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dithranol adverse reaction |
Causative agent (attribute) |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol ointment adverse reaction |
Causative agent (attribute) |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol cream adverse reaction |
Causative agent (attribute) |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol paste adverse reaction |
Causative agent (attribute) |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Allergy to dithranol (finding) |
Causative agent (attribute) |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol ointment allergy |
Causative agent (attribute) |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol cream allergy |
Causative agent (attribute) |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol paste allergy |
Causative agent (attribute) |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol overdose |
Causative agent (attribute) |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Accidental dithranol overdose |
Causative agent (attribute) |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Intentional dithranol overdose |
Causative agent (attribute) |
True |
Dithranol |
Inferred relationship |
Some |
1 |
surdose de dithranol d'intention indéterminée |
Causative agent (attribute) |
False |
Dithranol |
Inferred relationship |
Some |
1 |
Anthralin ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol+salicylic acid 0.25%/1.6% scalp gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol triacetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol [generic additions] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 0.1% ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 0.2% ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 0.5% ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 1.5% ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 0.2% paste BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 0.5% paste BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Product containing precisely dithranol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 0.1% paste BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 1% paste BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol 2.5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol 5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol 1 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 0.2% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 0.4% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin paste |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 0.25% topical cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 1.0% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 10mg/g cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Product containing dithranol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Product containing dithranol and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dithranol |
Inferred relationship |
Some |
2 |
Dithranol triacetate (substance) |
Is a |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol 10 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol burn (disorder) |
Causative agent (attribute) |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol paste allergy |
Causative agent (attribute) |
False |
Dithranol |
Inferred relationship |
Some |
1 |
Allergy to dithranol (finding) |
Causative agent (attribute) |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol ointment allergy |
Causative agent (attribute) |
False |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol cream allergy |
Causative agent (attribute) |
False |
Dithranol |
Inferred relationship |
Some |
1 |
Anthralin 0.2% cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Anthralin 0.4% cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dithranol |
Inferred relationship |
Some |
|
Dithranol-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dithranol |
Inferred relationship |
Some |
1 |
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol 20 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol 20 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Product containing precisely dithranol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Product containing precisely dithranol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol 2.5 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol 2.5 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol 5 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol 5 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol 10 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol 10 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol 1 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol 1 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Dithranol |
Inferred relationship |
Some |
1 |
Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Dithranol |
Inferred relationship |
Some |
1 |
Coal tar- and dithranol- and salicylic acid-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dithranol |
Inferred relationship |
Some |
2 |
Product containing dithranol and salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dithranol |
Inferred relationship |
Some |
2 |
Product containing coal tar and dithranol and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dithranol |
Inferred relationship |
Some |
2 |
Dithranol triacetate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dithranol |
Inferred relationship |
Some |
|
Coal tar and dithranol and salicylic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dithranol |
Inferred relationship |
Some |
2 |
Product containing only dithranol and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dithranol |
Inferred relationship |
Some |
2 |
Dithranol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Product containing only coal tar and dithranol and salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dithranol |
Inferred relationship |
Some |
2 |
Product containing only dithranol and salicylic acid in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dithranol |
Inferred relationship |
Some |
2 |
Product containing only dithranol in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol 10 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol 10 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Dithranol burn (disorder) |
Causative agent (attribute) |
True |
Dithranol |
Inferred relationship |
Some |
1 |
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dithranol |
Inferred relationship |
Some |
2 |
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dithranol |
Inferred relationship |
Some |
2 |
Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dithranol |
Inferred relationship |
Some |
2 |
Product containing precisely dithranol 2.5 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dithranol |
Inferred relationship |
Some |
2 |